At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1,531 enrolled
Drug / intervention
Amlodipine besylate/atorvastatin calcium single pill combinationdrug
Likely dose
Amlodipine besylate/atorvastatin calcium single pill combination 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Cluster Randomized Trial On Cardiovascular Risk Factor Management: Caduet Versus Usual Care In Subjects With Hypertension And Additional Cardiovascular Risk Factors In Clinical Practice
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·interventional·Posted Dec 5, 2006·Updated Jan 28, 2021
In Brief
A Phase 4 clinical trial evaluating Amlodipine besylate/atorvastatin calcium single pill combination for Hypertension and Hypercholesterolemia. Completed, enrolled 1,531 participants across 125 sites in 20 countries.
Detailed Summary
To investigate whether a Caduet based treatment strategy might result in greater reduction in total cardiovascular risk as compared to usual care in subjects with hypertension and additional risk factors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension, Hypercholesterolemia
CountriesCosta Rica, Croatia, Czechia, Dominican Republic, Indonesia, Jordan, Kuwait, Lebanon, Malaysia, Mexico, Panama, Philippines, Russia, Saudi Arabia, South Korea, Taiwan, Thailand, Turkey (Türkiye), United Arab Emirates, Venezuela
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 2006
Enrollment StartMar 2007
Primary CompletionOct 2009
TodayJul 2026
First PostedDec 5, 2006
Enrollment StartMar 1, 2007
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 19.6 years ago
Interventions
Amlodipine besylate/atorvastatin calcium single pill combinationdrug
Open label amlodipine besylate/atorvastatin calcium single pill combination at multiple doses: 5/10, 10/10, 5/20, 10/20 mg prescribed at the investigator's discretion